Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 4/20 | 1.00 |
| ▸ | GRIN3B | O60391 | 4/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 4/20 | 1.00 |
| ▸ | GRIN2A | Q12879 | 4/20 | 1.00 |
| ▸ | GRIN2B | Q13224 | 4/20 | 1.00 |
| ▸ | GRIN2C | Q14957 | 4/20 | 1.00 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | STAT6 | P42226 | 1/20 | 0.38 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28240546 | 0.97 | GRIN2D (0.94) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL3027024 | 0.97 | GRIN2D (0.94) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL15101088 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL15211032 | 0.85 | GRIN2D (0.73) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL17582395 | 0.84 | — | — | |
| SCHEMBL21165989 | 0.84 | GRIN2D (0.71) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL4132620 | 0.82 | GRIN2D (0.70) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL13968181 | 0.82 | GRIN2D (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL26605077 | 0.80 | GRIN2D (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL13968177 | 0.80 | GRIN2D (0.64) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011687-A | High-toughness epoxy resin-based carbon fiber prepreg and preparation method thereof | 江苏美伦新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-116217484-B | Naphthalimide derivative based on methylene adamantane modification as well as preparation method and application thereof | 苏州大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117202750-A | Doped perovskite thin film, preparation method thereof and perovskite solar cell | 杭州纤纳光电科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116395671-A | Preparation method of magnetic carbon quantum dot with high relaxation rate | 中国科学院上海微系统与信息技术研究所 | 2023-07-07 | — | — | CN | claimed |
| CN-116285974-A | Preparation method of carbon-based quantum dot with high quantum yield and light stability | 中国科学院上海微系统与信息技术研究所 | 2023-06-23 | — | — | CN | claimed |
| CN-116217484-A | Naphthalimide derivative based on methylene adamantane modification as well as preparation method and application thereof | 苏州大学 | 2023-06-06 | — | — | CN | claimed |
| EP-3520152-B1 | SHELLING OF HALIDE PEROVSKITE NANOPARTICLES FOR THE PREVENTION OF ANION EXCHANGE | NANOCO TECHNOLOGIES LTD (GB) | 2022-07-06 | — | — | EP | claimed |
| CN-113264909-A | Andrographolide derivative and preparation method and application thereof | 沈阳药科大学 | 2021-08-17 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-110615466-A | One-step crystallization preparation CsPbX3Method for preparing perovskite quantum dot film | 华北电力大学 | 2019-12-27 | — | — | CN | claimed |
| US-20130143962-A1 | Adamantyl Derivatives as Therapeutic Agents | WOMEN & INFANTS' HOSPITAL OF RHODE ISLAND (US) | 2013-06-06 | — | — | US | claimed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | claimed |
| CN-102258788-B | Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof | UNIV NANKAI | 2012-11-07 | — | — | CN | claimed |
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | claimed |
| CN-102258788-A | Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof | — | 2011-11-30 | — | — | CN | claimed |
| EP-2340811-A1 | Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same | Sungkyunkwan University Foundation for Corporate Collaboration (KR) | 2011-07-06 | — | — | EP | claimed |
| US-20110150978-A1 | PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2011-06-23 | — | — | US | claimed |
| CN-1665801-B | Anti tubercular drug: compositions and methods | DEPT OF HEALTH AND HUMAN SERVI | 2011-05-11 | — | — | CN | claimed |
| EP-0139504-B1 | ADAMANTYLAMINE/LONG CHAIN ALKYLAMINE CATALYSTS AND USE IN PARAFFIN-OLEFIN ALKYLATION PROCESS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1988-06-08 | — | — | EP | claimed |
| EP-0139504-A1 | Adamantylamine/long chain alkylamine catalysts and use in paraffin-olefin alkylation process | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1985-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | GRIN2D 399/4885GRIN3B 217/4885GRIN1 215/4885 |
| US-20130143962-A1 | Adamantyl Derivatives as Therapeutic Agents | MCL1, TOP2A, TP53 | GRIN2D 3200/4885GRIN3B 1402/4885GRIN1 2273/4885 |
| US-20110150978-A1 | PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME | CHMP4B, PEBP1, ABCC1 | GRIN2D 3721/4885GRIN3B 867/4885GRIN1 1078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.